Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 506
Ph III recruiting: 46
Growth YoY: +21.9%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 1–29 of 29 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05041335	Wet Heparinized Suction for Abdominal Cancer(EUS Heparin)	withdrawn	N/A	0	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Sep 17, 2026	clinicaltrials
NCT02872831	Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle	withdrawn	N/A	0	Thomas Jefferson UniversityOTHER	1	Apr 13, 2026	clinicaltrials